Literature DB >> 23219716

Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration.

Douglas W Strand1, David J DeGraff, Ming Jiang, Mansoureh Sameni, Omar E Franco, Harold D Love, William J Hayward, Opal Lin-Tsai, Anne Y Wang, Justin M M Cates, Bonnie F Sloane, Robert J Matusik, Simon W Hayward.   

Abstract

Hindgut-derived endoderm can differentiate into rectal, prostatic, and bladder phenotypes. Stromal-epithelial interactions are crucial for this development; however, the precise mechanisms by which epithelium responds to stromal cues remain unknown. We have previously reported ectopic expression of peroxisome proliferator-activated receptor-γ2 (PPARγ2) increased androgen receptor expression and promoted differentiation of mouse prostate epithelium. PPARγ is also implicated in urothelial differentiation. Herein we demonstrate that knockdown of PPARγ2 in benign human prostate epithelial cells (BHPrEs) promotes urothelial transdifferentiation. Furthermore, in vitro and in vivo heterotypic tissue regeneration models with embryonic bladder mesenchyme promoted urothelial differentiation of PPARγ2-deficient BHPrE cells, and deficiency of both PPARγ isoforms 1 and 2 arrested differentiation. Because PTEN deficiency is cooperative in urothelial pathogenesis, we engineered BHPrE cells with combined knockdown of PPARγ and PTEN and performed heterotypic recombination experiments using embryonic bladder mesenchyme. Whereas PTEN deficiency alone induced latent squamous differentiation in BHPrE cells, combined PPARγ and PTEN deficiency accelerated the development of keratinizing squamous metaplasia (KSM). We further confirmed via immunohistochemistry that gene expression changes in metaplastic recombinants reflected human urothelium undergoing KSM. In summary, these data suggest that PPARγ isoform expression provides a molecular basis for observations that adult human epithelium can be transdifferentiated on the basis of heterotypic mesenchymal induction. These data also implicate PPARγ and PTEN inactivation in the development of KSM.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219716      PMCID: PMC3562729          DOI: 10.1016/j.ajpath.2012.10.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  PPARgamma-regulated tight junction development during human urothelial cytodifferentiation.

Authors:  Claire L Varley; Mary A E Garthwaite; William Cross; Jennifer Hinley; Ludwik K Trejdosiewicz; Jennifer Southgate
Journal:  J Cell Physiol       Date:  2006-08       Impact factor: 6.384

2.  PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.

Authors:  L P Weng; W M Smith; J L Brown; C Eng
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

3.  Plasticity of the urothelial phenotype: effects of gastro-intestinal mesenchyme/stroma and implications for urinary tract reconstruction.

Authors:  Y Li; W Liu; S W Hayward; G R Cunha; L S Baskin
Journal:  Differentiation       Date:  2000-10       Impact factor: 3.880

4.  Mesenchymal reprogramming of adult human epithelial differentiation.

Authors:  S Aboseif; A El-Sakka; P Young; G Cunha
Journal:  Differentiation       Date:  1999-10       Impact factor: 3.880

5.  Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.

Authors:  K I Nakashiro; Y Hayashi; A Kita; T Tamatani; A Chlenski; N Usuda; K Hattori; J K Reddy; R Oyasu
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.

Authors:  A Di Cristofano; M De Acetis; A Koff; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

7.  JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate.

Authors:  Anette Hübner; David J Mulholland; Claire L Standen; Maria Karasarides; Julie Cavanagh-Kyros; Tamera Barrett; Hongbo Chi; Dale L Greiner; Cathy Tournier; Charles L Sawyers; Richard A Flavell; Hong Wu; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 8.  Pathological and molecular aspects of prostate cancer.

Authors:  Angelo M DeMarzo; William G Nelson; William B Isaacs; Jonathan I Epstein
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

9.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.

Authors:  Sylvia Julien Grille; Alfonso Bellacosa; John Upson; Andres J Klein-Szanto; Frans van Roy; Whaseon Lee-Kwon; Mark Donowitz; Philip N Tsichlis; Lionel Larue
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

10.  Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.

Authors:  Cory Abate-Shen; Whitney A Banach-Petrosky; Xiaohui Sun; Kyriakos D Economides; Nishita Desai; Jeffery P Gregg; Alexander D Borowsky; Robert D Cardiff; Michael M Shen
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

View more
  11 in total

1.  Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.

Authors:  Opal L Reddy; Justin M Cates; Lan L Gellert; Henry S Crist; Zhaohai Yang; Hironobu Yamashita; John A Taylor; Joseph A Smith; Sam S Chang; Michael S Cookson; Chaochen You; Daniel A Barocas; Magdalena M Grabowska; Fei Ye; Xue-Ru Wu; Yajun Yi; Robert J Matusik; Klaus H Kaestner; Peter E Clark; David J DeGraff
Journal:  Am J Pathol       Date:  2015-05       Impact factor: 4.307

2.  Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.

Authors:  Chunming Guo; Zarine R Balsara; Warren G Hill; Xue Li
Journal:  Development       Date:  2017-01-03       Impact factor: 6.868

3.  Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.

Authors:  Renjie Jin; Connor Forbes; Nicole L Miller; Douglas Strand; Thomas Case; Justin M Cates; Hye-Young H Kim; Phillip Wages; Ned A Porter; Krystin M Mantione; Sarah Burke; James L Mohler; Robert J Matusik
Journal:  Prostate       Date:  2022-07-12       Impact factor: 4.012

4.  Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.

Authors:  Shyama Majumdar; Edward M Gong; Dolores Di Vizio; Jonathan Dreyfuss; David J Degraff; Martin H Hager; Peter J Park; Joaquim Bellmunt; Robert J Matusik; Jonathan E Rosenberg; Rosalyn M Adam
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

5.  NF-κB and androgen receptor variant expression correlate with human BPH progression.

Authors:  David C Austin; Douglas W Strand; Harold L Love; Omar E Franco; Alex Jang; Magdalena M Grabowska; Nicole L Miller; Omar Hameed; Peter E Clark; Jay H Fowke; Robert J Matusik; Ren J Jin; Simon W Hayward
Journal:  Prostate       Date:  2015-12-28       Impact factor: 4.104

Review 6.  [Preneoplastic lesions and precursors of urothelial cancer].

Authors:  R Knüchel-Clarke; N T Gaisa
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

7.  Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.

Authors:  Pontus Eriksson; Mattias Aine; Srinivas Veerla; Fredrik Liedberg; Gottfrid Sjödahl; Mattias Höglund
Journal:  BMC Med Genomics       Date:  2015-05-26       Impact factor: 3.063

8.  FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.

Authors:  Joshua I Warrick; Vonn Walter; Hironobu Yamashita; Eunah Chung; Lauren Shuman; Vasty Osei Amponsa; Zongyu Zheng; Wilson Chan; Tiffany L Whitcomb; Feng Yue; Tejaswi Iyyanki; Yuka I Kawasawa; Matthew Kaag; Wansong Guo; Jay D Raman; Joo-Seop Park; David J DeGraff
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

9.  Differential transcription factor expression by human epithelial cells of buccal and urothelial derivation.

Authors:  Arianna Hustler; Ian Eardley; Jennifer Hinley; Joanna Pearson; Felix Wezel; Francois Radvanyi; Simon C Baker; Jennifer Southgate
Journal:  Exp Cell Res       Date:  2018-05-26       Impact factor: 3.905

10.  The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.

Authors:  Emuejevoke Olokpa; Adrienne Bolden; LaMonica V Stewart
Journal:  J Cell Physiol       Date:  2016-03-14       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.